Alcami and Parenteral Drug Association Southeast (PDA SE) Chapter Host July Talk & Tour Event to Benefit Leukemia and Lymphoma Society (LLS)

Speakers will address solving common development and manufacturing challenges for small to mid-sized biotechs, followed by lab tours and networking event.

Durham, North Carolina – (May 28, 2024) – Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced it will co-host an upcoming Talk & Tour event with the Parenteral Drug Association’s Southeast Chapter on July 25 at the North Carolina Biotechnology Center from 12:30 – 5 pm. Open to the public at a cost of $25 for PDA members, $35 for nonmembers and $10 for students, all registration fees will be donated to the Leukemia & Lymphoma Society’s (LLS) Light the Night Fundraiser. Funds raised through Light the Night enable the LLS to fund treatments for all forms of blood cancers. LLS has helped fund over 70% of FDA-approved blood cancer treatments since 2016. Register here.

During the afternoon, participants will hear from Lexie Petsikas of the Leukemia and Lymphoma Society, followed by Alex Drennan, Alcami Director of Manufacturing, Jeremy Mainville, Alcami Director of Laboratory Operations, and Elliott Franco, Alcami VP of Laboratory Operations, who will share key learnings in sterile fill-finish manufacturing, CDMO microbiology capabilities and lab biologic capabilities, as well as project streamlining with a focus on oncology. The event includes tours of Alcami’s cutting-edge sterile fill-finish suites in the heart of RTP (with transportation provided) plus a networking reception and heavy hors d’oeuvres.

“We are delighted to partner with the Parenteral Drug Association Southeast Chapter to offer this educational session to benefit the Leukemia and Lymphoma Society’s important 2024 Triangle Light the Night fundraiser,” said Alcami Senior Vice President of Sales Kerrie Powell. “Our work at Alcami centers around helping speed the delivery of innovative treatments to the patients who need them, and no organization is more deserving of the spotlight than the LLS. We are honored to help support their vital efforts to find and fund the most promising research leading to new treatment discovery and novel ways to use existing treatments for every person with blood cancer.”

And Lexie Petsikas, LLS Campaign Development Manager, said, “We are grateful for the opportunity to share the LLS mission and highlight Light the Night, one of our biggest campaigns and events, at the Alcami Talk and Tour. It is vital to have the support of companies like Alcami that are committed and focused on helping deliver innovative treatments to cancer patients. Thank you to the Alcami team for backing the LLS and hosting an event to raise lifesaving funds in support of our mission and Light the Night.”

The first in an ongoing series of events with the PDA’s Southeast Chapter that focus on its mission to connect people, science and regulation, Alcami will next co-host a Talk & Tour event on September 17 in Charleston, SC. Alcami also serves as an annual sponsor of the Parenteral Drug Association Southeast Chapter.

Media Contact:

Pam O’Connor, Director of Communications

Pamela.oconnor@alcami.com

About Alcami

Alcami is a contract development and manufacturing organization headquartered in NC with 45+ years of experience advancing products through the development lifecycle. Alcami provides fully integrated lab services along with drug product manufacturing, GMP pharma storage, and support services including environmental monitoring, calibration, validation and metrology. Alcami’s private equity ownership includes GHO Capital, The Vistria Group, and Ampersand Capital Partners. For more information, please visit alcami.com.

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society® (LLS) is the global leader in the fight against blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease, and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.

Founded in 1949 and headquartered in Rye Brook, NY, LLS has regions throughout the United States and Canada. To learn more, visit LLS.org.

About PDASE
The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information with a mission on Connecting People, Science and Regulation®. PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers high-quality, relevant education to the industry. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical/biopharmaceutical manufacturing science and regulation, so members can better serve patients. PDA Southeast Chapter's Executive Board and Committee chairs consist of professionals in the biotech, pharmaceutical, medical device, and clinical industries. The Executive Board works with Committee Heads to deliver events and collaboration with industry. The Southeast Chapter's region covers eleven states including NC, SC, VA, TN, GA, FL, KY, AL, and MS.